Cell cycle control in the liver

The Liver: Biology and Pathobiology

Volumn , Issue , 2009, Pages 1015-1027

  Albrecht, Jeffrey H ^a,b   Mullany, Lisa K ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889859117     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747919.ch62     Document Type: Chapter

References (143)

1. Morgan, D.O. (2007) The Cell Cycle: Principles of Control, New Science Press, London.
2. Weinberg, R.A. (2007) pRb and Control of the Cell Cycle Clock. In: The Biology of Cancer, Garland Science, Taylor and Francis Group, LLC, New York, 255-306.
3. Malumbres, M. and Barbacid, M. (2001) To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer, 1, 222-31.
4. Vermeulen, K., Van Bockstaele, D.R. and Berneman, Z.N. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif, 36, 131-49.
5. Hahn, W.C. and Weinberg, R.A. (2002) Modelling the molecular circuitry of cancer. Nat Rev Cancer, 2, 331-41.
6. Deshpande, A., Sicinski, P. and Hinds, P.W. (2005) Cyclins and cdks in development and cancer: a perspective. Oncogene, 24, 2909-15.
7. Tapon, N., Moberg, K.H. and Hariharan, I.K. (2001) The coupling of cell growth to the cell cycle. Curr Opin Cell Biol, 13, 731-37.
8. Prober, D.A. and Edgar, B.A. (2001) Growth regulation by oncogenes - new insights from model organisms. Curr Opin Genet Dev, 11, 19-26.
9. Cormier, P., Pyronnet, S., Salaun, P., Mulner-Lorillon, O. and Sonenberg, N. (2003) Cap-dependent translation and control of the cell cycle. Prog Cell Cycle Res, 5, 469-75.
10. Jones, S.M. and Kazlauskas, A. (2001) Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat Cell Biol, 3, 165-72.
11. Fassett, J.T., Tobolt, D., Nelsen, C.J., Albrecht, J.H. and Hansen, L.K. (2003) The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes. J Biol Chem, 278, 31691-700.
12. Villanueva, J., Yung, Y., Walker, J.L. and Assoian, R.K. (2007) ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol Biol Cell, 18, 1457-63.
13. Talarmin, H., Rescan, C., Cariou, S., Glaise, D., Zanninelli, G., Bilodeau, M., Loyer, P. et al. (1999) The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol, 19, 6003-11.
14. Gupta, S. (2000) Hepatic polyploidy and liver growth control. Semin Cancer Biol, 10, 161-71.
15. Guidotti, J.E., Bregerie, O., Robert, A., Debey, P., Brechot, C. and Desdouets, C. (2003) Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem, 278, 19095-101.
16. Nasmyth, K. (2001) A prize for proliferation. Cell, 107, 689-701.
17. Loyer, P., Cariou, S., Glaise, D., Bilodeau, M., Baffet, G. and Guguen-Guillouzo, C. (1996) Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem, 271, 11484-92.
18. Albrecht, J.H., Rieland, B.M., Nelsen, C.J. and Ahonen, C.L. (1999) Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am J Physiol, 277, G1207-16.
19. Rickheim, D.G., Nelsen, C.J., Fassett, J.T., Timchenko, N.A., Hansen, L.K. and Albrecht, J.H. (2002) Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Hepatology, 36, 30-38.
20. Alt, J.R., Gladden, A.B. and Diehl, J.A. (2002) p21(Cip1) promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem, 277, 8517-23.
21. Parry, D., Mahony, D., Wills, K. and Lees, E. (1999) Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol, 19, 1775-83.
22. Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M.F., Roberts, J.M. and Sherr, C.J. (1999) The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J, 18, 1571-83.
23. Blain, S.W. (2008) Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle, 7, 892-98.
24. Albrecht, J.H., Poon, R.Y., Ahonen, C.L., Rieland, B.M., Deng, C. and Crary, G.S. (1998) Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene, 16, 2141-50.
25. Jaime, M., Pujol, M.J., Serratosa, J., Pantoja, C., Canela, N., Casanovas, O., Serrano, M. et al. (2002) The p21(Cip1) protein, a cyclin inhibitor, regulates the levels and the intracellular localization of CDC25A in mice regenerating livers. Hepatology, 35, 1063-71.
26. Luedde, T., Rodriguez, M.E., Tacke, F., Xiong, Y., Brenner, D.A. and Trautwein, C. (2003) p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver. Hepatology, 37, 833-41.
27. Pagano, M. and Jackson, P.K. (2004) Wagging the dogma: tissue-specific cell cycle control in the mouse embryo. Cell, 118, 535.
28. Lee, Y.M. and Sicinski, P. (2006) Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human. Cell Cycle, 5, 2110-14.
29. Berthet, C. and Kaldis, P. (2007) Cell-specific responses to loss of cyclin-dependent kinases. Oncogene, Jul 5; 26(31): 4469-77.
30. Santamaria, D. and Ortega, S. (2006) Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci, 11, 1164-88.
31. Sanchez, I. and Dynlacht, B.D. (2005) New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol, 16, 311.
32. Kozar, K. and Sicinski, P. (2005) Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle, 4, 388-91.
33. Geng, Y., Lee, Y.-M., Welcker, M., Swanger, J., Zagozdzon, A., Winer, J.D., Roberts, J.M. et al. (2007) Kinase-independent function of cyclin E. Mol Cell, 25, 127.
34. Matsumoto, Y. and Maller, J.L. (2004) A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science, 306, 885-88.
35. Coqueret, O. (2002) Linking cyclins to transcriptional control. Gene, 299, 35-55.
36. Fu, M., Wang, C., Li, Z., Sakamaki, T. and Pestell, R.G. (2004) Minireview: cyclin D1: normal and abnormal functions. Endocrinology, 145, 5439-47.
37. Li, Z., Wang, C., Prendergast, G.C. and Pestell, R.G. (2006) Cyclin D1 functions in cell migration. Cell Cycle, 5, 2440-42.
38. Nelsen, C.J., Rickheim, D.G., Tucker, M.M., Hansen, L.K. and Albrecht, J.H. (2003) Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem, 278, 3656-63.
39. Edgar, B.A. (2004) Growth and cell cycle control in drosophila. In: Cell Growth: Control of Cell Size (eds M.N. Hall, M.C. Raff and G. Thomas), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 23-84.
40. Cockcroft, C.E., den Boer, B.G., Healy, J.M. and Murray, J.A. (2000) Cyclin D control of growth rate in plants. Nature, 405, 575-79.
41. Imanishi, Y., Hosokawa, Y., Yoshimoto, K., Schipani, E., Mallya, S., Papanikolaou, A., Kifor, O. et al. (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest, 107, 1093-102.
42. Yu, Q., Geng, Y. and Sicinski, P. (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature, 411, 1017-21.
43. Deane, N.G., Parker, M.A., Aramandla, R., Diehl, L., Lee, W.J., Washington, M.K., Nanney, L.B. et al. (2001) Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res, 61, 5389-95.
44. Landis, M.W., Pawlyk, B.S., Li, T., Sicinski, P. and Hinds, P.W. (2006) Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell, 9, 13.
45. Grisham, J.W. (2004) Molecular biology of hepatocellular carcinoma. In: Gastrointestinal Oncology (eds J.L. Abbruzzese, D.B. Evans, C.G. Willett and C. Fenoglio-Preiser), Oxford University Press, New York, pp. 471-506.
46. Willenbring, H., Sharma, A.D., Vogel, A., Lee, A.Y., Rothfuss, A., Wang, Z., Finegold, M. et al. (2008) Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Cancer Cell, 14, 59.
47. Fausto, N., Campbell, J.S. and Riehle, K.J. (2006) Liver regeneration. Hepatology, 43, S45-53.
48. Fausto, N. (2000) Liver regeneration. J Hepatol, 32, 19-31.
49. Lu, X.P., Koch, K.S., Lew, D.J., Dulic, V., Pines, J., Reed, S.I., Hunter, T. et al. (1992) Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J Biol Chem, 267, 2841-44.
50. Zindy, F., Lamas, E., Chenivesse, X., Sobczak, J., Wang, J., Fesquet, D., Henglein, B. et al. (1992) Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun, 182, 1144-54.
51. Albrecht, J.H., Hoffman, J.S., Kren, B.T. and Steer, C.J. (1993) Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am J Physiol, 265, G857-64.
52. Loyer, P., Glaise, D., Cariou, S., Baffet, G., Meijer, L. and Guguen-Guillouzo, C. (1994) Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J BiolChem, 269, 2491-500.
53. Trembley, J.H., Kren, B.T. and Steer, C.J. (1994) Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver. Cell Growth Differ, 5, 99-108.
54. Albrecht, J.H., Hu, M.Y. and Cerra, F.B. (1995) Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun, 209, 648-55.
55. Sun, W., Lee, D.K., Lee, C.C. and Kim, K. (1996) Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo. Mol Reprod Dev, 43, 414-20.
56. Trembley, J.H., Ebbert, J.O., Kren, B.T. and Steer, C.J. (1996) Differential regulation of cyclin B1 RNA and protein expression during hepatocyte growth in vivo. Cell Growth Differ, 7, 903-16.
57. Albrecht, J.H., Meyer, A.H. and Hu, M.Y. (1997) Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology, 25, 557-63.
58. Ehrenfried, J.A., Ko, T.C., Thompson, E.A. and Evers, B.M. (1997) Cell cycle-mediated regulation of hepatic regeneration. Surgery, 122, 927-35.
59. Rininger, J.A., Goldsworthy, T.L. and Babish, J.G. (1997) Time course comparison of cell-cycle protein expression following partial hepatectomy and WY14, 643-induced hepatic cell proliferation in F344 rats. Carcinogenesis, 18, 935-41.
60. Verges, M., Castro, A., Jaumot, M., Bachs, O. and Enrich, C. (1997) Cyclin A is present in the endocytic compartment of rat liver cells and increases during liver regeneration. Biochem Biophys Res Commun, 230, 49-53.
61. Garriga, J., Limon, A., Mayol, X., Rane, S.G., Albrecht, J.H., Reddy, E.P., Andres, V. et al. (1998) Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J, 333, 645-54.
62. Kato, A., Ota, S., Bamba, H., Wong, R.M., Ohmura, E., Imai, Y. and Matsuzaki, F. (1998) Regulation of cyclin D-dependent kinase activity in rat liver regeneration. Biochem Biophys Res Commun, 245, 70-74.
63. Menjo, M., Ikeda, K. and Nakanishi, M. (1998) Regulation of G1 cyclin-dependent kinases in liver regeneration. J Gastroenterol Hepatol, 13 (Suppl S100-5), S100-5.
64. Jaumot, M., Estanyol, J.M., Serratosa, J., Agell, N. and Bachs, O. (1999) Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Hepatology, 29, 385-95.
65. Takahashi, H., Menjo, M., Kaneko, Y., Ikeda, K., Matsushime, H. and Nakanishi, M. (2000) Cdk4 activation is dependent on the subunit rearrangement in the complexes. Biochem Biophys Res Commun, 267, 388-93.
66. Turmelle, Y.P., Shikapwashya, O., Tu, S., Hruz, P.W., Yan, Q. and Rudnick, D.A. (2006) Rosiglitazone inhibits mouse liver regeneration. FASEB J, 20, 2609-11.
67. Kossatz, U., Dietrich, N., Zender, L., Buer, J., Manns, M.P. and Malek, N.P. (2004) Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev, 18, 2602-7.
68. Albrecht, J.H. and Hansen, L.K. (1999) Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ, 10, 397-404.
69. Nelsen, C.J., Hansen, L.K., Rickheim, D.G., Chen, C., Stanley, M.K., Krek, W. and Albrecht, J.H. (2001) Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2. Oncogene, 20, 1825-31.
70. Koteish, A., Yang, S., Lin, H., Huang, J. and Diehl, A.M. (2002) Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcohol Clin Exp Res, 26, 1710-18.
71. Nelsen, C.J., Rickheim, D.G., Tucker, M.M., McKenzie, T.J., Hansen, L.K., Pestell, R.G. and Albrecht, J.H. (2003) Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J Biol Chem, 278, 25853-58.
72. Yang, S.Q., Lin, H.Z., Yin, M., Albrecht, J.H. and Diehl, A.M. (1998) Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol, 275, G696-704.
73. Goupil, D., Ethier, C., Zarnegar, R. and Gascon-Barre, M. (1997) Hepatic expression of regeneration marker genes following partial hepatectomy in the rat. Influence of 1, 25-dihydroxyvitamin D3 in hypocalcemia. J Hepatol, 26, 659-68.
74. Anderson, S.P., Yoon, L., Richard, E.B., Dunn, C.S., Cattley, R.C. and Corton, J.C. (2002) Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology, 36, 544-54.
75. Kato, A., Bamba, H., Shinohara M., Yamauchi, A., Ota, S., Kawamoto, C. and Yoshida, Y. (2005) Relationship between expression of cyclin D1 and impaired liver regeneration observed in fibrotic or cirrhotic rats. J Gastroenterol Hepatol, 20, 1198-205.
76. Torbenson, M., Yang, S.Q., Liu, H.Z., Huang, J., Gage, W. and Diehl, A.M. (2002) STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol, 161, 155-61.
77. Cressman, D.E., Greenbaum, L.E., DeAngelis, R.A., Ciliberto, G., Furth, E.E., Poli, V. and Taub, R. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 274, 1379-83.
78. Hines, I.N., Kremer, M., Isayama, F., Perry, A.W., Milton, R.J., Black, A.L., Byrd, C.L. et al. (2007) Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology, 46, 229-41.
79. Coutant, A., Rescan, C., Gilot, D., Loyer, P., Guguen-Guillouzo, C. and Baffet, G. (2002) PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology, 36, 1079-88.
80. Schwabe, R.F., Bradham, C.A., Uehara, T., Hatano, E., Bennett, B.L., Schoonhoven, R. and Brenner, D.A. (2003) c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology, 37, 824-32.
81. Hansen, L.K. and Albrecht, J.H. (1999) Regulation of the hepatocyte cell cycle by type I collagen matrix: role of cyclin D1. J Cell Sci, 112, 2971-81.
82. Ledda-Columbano, G.M., Pibiri, M., Loi, R., Perra, A., Shinozuka, H. and Columbano, A. (2000) Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-bis[2-(3, 5-dichloropyridyloxy)] benzene. Am J Pathol, 156, 91-97.
83. Pibiri, M., Ledda-Columbano, G.M., Cossu, C., Simbula, G., Menegazzi, M., Shinozuka, H. and Columbano, A. (2001) Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J, 15, 1006-13.
84. Kren, B.T. and Steer, C.J. (1996) Posttranscriptional regulation of gene expression in liver regeneration: role of mRNA stability. FASEB J, 10, 559-73.
85. Goggin, M.M., Nelsen, C.J., Kimball, S.R., Jefferson, L.S., Morley, S.J. and Albrecht, J.H. (2004) Rapamycin-sensitive induction of eukaryotic initiation factor 4F in regenerating mouse liver. Hepatology, 40, 537-44.
86. Boylan, J.M. and Gruppuso, P.A. (2005) D-type cyclins and G1 progression during liver development in the rat. Biochem Biophys Res Commun, 330, 722-30.
87. Mullany, L.K., White, P., Hanse, E.A., Nelsen, C.J., Goggin, M.M., Mullany, J.E., Anttila, C.K. et al. (2008) Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle, 7, 2215-24.
88. Ledda-Columbano, G.M., Pibiri, M., Concas, D., Cossu, C., Tripodi, M. and Columbano, A. (2002) Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli. Hepatology, 36, 1098-105.
89. Michalopoulos, G.K. (2007) Liver regeneration. J Cell Physiol, 213, 286-300.
90. McEvoy, J.D., Kossatz, U., Malek, N. and Singer, J.D. (2007) Constitutive turnover of cyclin E by Cul3 maintains quiescence. Mol Cell Biol, 27, 3651-66.
91. Mullany, L.K., Nelsen, C.J., Hanse, E.A., Goggin, M.M., Anttila, C.K., Peterson, M., Bitterman, P.B. et al. (2007) Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J Biol Chem, 282, 21244-52.
92. Volarevic, S., Stewart, M.J., Ledermann, B., Zilberman, F., Terracciano, L., Montini, E., Grompe, M. et al. (2000) Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science, 288, 2045-47.
93. Garcia, Z., Kumar, A., Marques, M., Cortes, I. and Carrera, A.C. (2006) Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J, 25, 655-61.
94. Zschemisch, N.H., Liedtke, C., Dierssen, U., Nevzorova, Y.A., Wustefeld, T., Borlak, J., Manns, M.P. et al. (2006) Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology, 44, 164-73.
95. Serfas, M.S., Goufman, E., Feuerman, M.H., Gartel, A.L. and Tyner, A.L. (1997) p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ, 8, 951-61.
96. Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y. and Van Dyke, T. (1996) Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev, 10, 245-60.
97. Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L. et al. (2006) c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev, 20, 2306-14.
98. Nelsen, C.J., Rickheim, D.G., Timchenko, N.A., Stanley, M.W. and Albrecht, J.H. (2001) Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res, 61, 8564-68.
99. Grechez-Cassiau, A., Rayet, B., Guillaumond, F., Teboul, M. and Delaunay, F. (2008) The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem, 283, 4535-42.
100. Hui, T.T., Mizuguchi, T., Sugiyama, N., Avital, I., Rozga, J. and Demetriou, A.A. (2002) Immediate early genes and p21 regulation in liver of rats with acute hepatic failure. Am J Surg, 183, 457-63.
101. Crary, G.S. and Albrecht, J.H. (1998) Expression of cyclin-dependent kinase inhibitor p21 in human liver. Hepatology, 28, 738-43.
102. Brunt, E.M., Walsh, S.N., Hayashi, P.H., LaBundy, J. and Di Bisceglie, A.M. (2007) Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma. Liver Int, 27, 662.
103. Lunz, J.G. III, Tsuji, H., Nozaki, I., Murase, N. and Demetris, A.J. (2005) An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatology, 41, 1262-71.
104. Marshall, A., Rushbrook, S., Davies, S.E., Morris, L.S., Scott, I.S., Vowler, S.L., Coleman, N. et al. (2005) Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology, 128, 33-42.
105. Morita, T., Togo, S., Kubota, T., Kamimukai, N., Nishizuka, I., Kobayashi, T., Ichikawa, Y. et al. (2002) Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg, 9, 352-59.
106. Wagayama, H., Shiraki, K., Yamanaka, T., Sugimoto, K., Ito, T., Fujikawa, K., Takase, K. et al. (2001) p21WAF1/CTP1 expression and hepatitis virus type. Dig Dis Sci, 46, 2074-79.
107. Kwon, Y.H., Jovanovic, A., Serfas, M.S. and Tyner, A.L. (2003) The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury. J Biol Chem, 278, 30348-55.
108. Nguyen, L.N., Furuya, M.H., Wolfraim, L.A., Nguyen, A.P., Holdren, M.S., Campbell, J.S., Knight, B. et al. (2007) Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology, 45, 31-41.
109. Cimica, V., Batusic, D., Chen, Y., Hollemann, T., Pieler, T. and Ramadori, G. (2005) Transcriptome analysis of rat liver regeneration in a model of oval hepatic stem cells. Genomics, 86, 352.
110. Harada, K., Furubo, S., Ozaki, S., Hiramatsu, K., Sudo, Y. and Nakanuma, Y. (2001) Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol, 34, 500.
111. Gabele, E., Reif, S., Tsukada, S., Bataller, R., Yata, Y., Morris, T., Schrum, L.W. et al. (2005) The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J Biol Chem, 280, 13374-82.
112. Thorgeirsson, S.S. and Grisham, J.W. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet, 31, 339-46.
113. Greenbaum, L.E. (2004) Cell cycle regulation and hepatocarcinogenesis. Cancer Biol Ther, 3, 1200-7.
114. Levy, L., Renard, C.A., Wei, Y. and Buendia, M.A. (2002) Genetic alterations and oncogenic pathways in hepatocellular carcinoma. Ann N Y Acad Sci, 963, 21-36.
115. El-Serag, H.B. and Rudolph, K.L. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76.
116. Farinati, F., Cardin, R., D’Errico, A., De Maria, N., Naccarato, R., Cecchetto, A. and Grigioni, W. (1996) Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology, 23, 1468-75.
117. Delhaye, M., Louis, H., Degraef, C., Le Moine, O., Deviere, J., Gulbis, B., Jacobovitz, D. et al. (1996) Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology, 23, 1003-11.
118. Fang, J.W., Bird, G.L., Nakamura, T., Davis, G.L. and Lau, J.Y. (1994) Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet, 343, 820-23 [published erratum appears in Lancet (1994), 343 (8906), 1170].
119. Tarao, K., Ohkawa, S., Shimizu, A., Harada, M., Nakamura, Y., Ito, Y., Tamai, S. et al. (1994) Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer, 73, 1149-54.
120. Tarao, K., Shimizu, A., Ohkawa, S., Harada, M., Ito, Y., Tamai, S., Kuni, Y. et al. (1992) Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology, 103, 595-600.
121. Borzio, M., Trere, D., Borzio, F., Ferrari, A.R., Bruno, S., Roncalli, M., Colloredo, G. et al. (1998) Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol Pathol, 51, 96-101.
122. Nelsen, C.J., Kuriyama, R., Hirsch, B., Negron, V.C., Lingle, W.L., Goggin, M.M., Stanley, M.W. et al. (2005) Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem, 280, 768-76.
123. Duesberg, P., Li, R., Fabarius, A. and Hehlmann, R. (2005) The chromosomal basis of cancer. Cell Oncol, 27, 293-318.
124. Mayhew, C.N., Carter, S.L., Fox, S.R., Sexton, C.R., Reed, C.A., Srinivasan, S.V., Liu, X. et al. (2007) RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology, 133, 976-84.
125. Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M.K., Han, K., Lee, J.H. et al. (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med, 8, 1153-60.
126. Keyomarsi, K., Tucker, S.L., Buchholz, T.A., Callister, M., Ding, Y., Hortobagyi, G.N., Bedrosian, I. et al. (2002) Cyclin E and survival in patients with breast cancer. N Engl J Med, 347, 1566-75.
127. Raper, S.E., Chirmule, N., Lee, F.S., Wivel, N.A., Bagg, A., Gao, G.P., Wilson, J.M. et al. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab, 80, 148-58.
128. Ilan, Y., Saito, H., Thummala, N.R. and Chowdhury, N.R. (1999) Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis, 19, 49-59.
129. Spruck, C.H., Won, K.A. and Reed, S.I. (1999) Deregulated cyclin E induces chromosome instability. Nature, 401, 297-300.
130. Kalinichenko, V.V., Major, M.L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H.M., Dennewitz, M.B. et al. (2004) Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev, 18, 830-50.
131. Kalinichenko, V.V., Gusarova, G.A., Tan, Y., Wang, I.C., Major, M.L., Wang, X., Yoder, H.M. et al. (2003) Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Biol Chem, 278, 37888-94.
132. Wang, X., Kiyokawa, H., Dennewitz, M.B. and Costa, R.H. (2002) The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A, 99, 16881-86.
133. Campbell, T.C. and Junshi, C. (1994) Diet and chronic degenerative diseases: perspectives from China. Am J Clin Nutr, 59, 1153S-61S.
134. Hu, J.F., Cheng, Z., Chisari, F.V., Vu, T.H., Hoffman, A.R. and Campbell, T.C. (1997) Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet. Oncogene, 15, 2795-801.
135. Cheng, Z., Hu, J., King, J., Jay, G. and Campbell, T.C. (1997) Inhibition of hepatocellular carcinoma development in hepatitis B virus transfected mice by low dietary casein. Hepatology, 26, 1351-54.
136. Wheatley, D.N. and Campbell, E. (2002) Arginine catabolism, liver extracts and cancer. Pathol Oncol Res, 8, 18-25.
137. Leung-Pineda, V., Pan, Y., Chen, H. and Kilberg, M.S. (2004) Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization. Biochem J, 379, 79-88.
138. Liu, W., Kato, M., Akhand, A.A., Hayakawa, A., Takemura, M., Yoshida, S., Suzuki, H. et al. (1998) The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases. Int J Oncol, 12, 1321-26.
139. Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S.R., Monna, T. et al. (1995) Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer, 76, 743-49.
140. Suzui, M., Masuda, M., Lim, J.T., Albanese, C., Pestell, R.G. and Weinstein, I.B. (2002) Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res, 62, 3997-4006.
141. Okuno, M., Kojima, S., Matsushima-Nishiwaki, R., Tsurumi, H., Muto, Y., Friedman, S.L. and Moriwaki, H. (2004) Retinoids in cancer chemoprevention. Curr Cancer Drug Targets, 4, 285-98.
142. Koga, H. (2003) Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors? Cancer, 98, 661-67.
143. Murata, H., Tsuji, S., Tsujii, M., Sakaguchi, Y., Fu, H.Y., Kawano, S. and Hori, M. (2004) Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells. Lab Invest, 84, 1050-59.